# Coload Optimization Guided by Inferior Vena Cava Collapsibility Index

> **NCT04272632** · NA · COMPLETED · sponsor: **General Hospital of Ningxia Medical University** · enrollment: 168 (actual)

## Conditions studied

- Adverse Effect

## Interventions

- **DRUG:** 4 ml/kg group
- **DRUG:** 8 ml/kg group
- **DRUG:** 12 ml/kg group

## Key facts

- **NCT ID:** NCT04272632
- **Lead sponsor:** General Hospital of Ningxia Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2021-11-25
- **Final completion:** 2021-11-25
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2021-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04272632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04272632, "Coload Optimization Guided by Inferior Vena Cava Collapsibility Index". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04272632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*